ADRA1D receptor antagonist 1
|
A649539-10mg
|
≥98% |
1191908-14-1 |
10mg
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
Atropine methyl bromide
|
A649517-50mg
|
≥95% |
2870-71-5 |
50mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
Atropine methyl bromide
|
A649517-10mg
|
≥95% |
2870-71-5 |
10mg
|
¥ 5200.9
|
期货,请咨询 |
阿拉丁 |
Atropine methyl bromide
|
A649517-100mg
|
≥95% |
2870-71-5 |
100mg
|
¥ 21000.9
|
期货,请咨询 |
阿拉丁 |
Avacincaptad pegol sodium
|
A649501-1mg
|
≥98% |
1491144-00-3 |
1mg
|
¥ 9200.9
|
期货,请咨询 |
阿拉丁 |
Aristololactam II
|
A649493-5mg
|
|
55610-00-9 |
5mg
|
¥ 9350.9
|
期货,请咨询 |
阿拉丁 |
Aristololactam II
|
A649493-1mg
|
|
55610-00-9 |
1mg
|
¥ 3100.9
|
期货,请咨询 |
阿拉丁 |
1A-116
|
A649457-5mg
|
≥99% |
1430208-73-3 |
5mg
|
¥ 1400.9
|
期货,请咨询 |
阿拉丁 |
1A-116
|
A649457-50mg
|
≥99% |
1430208-73-3 |
50mg
|
¥ 7400.9
|
期货,请咨询 |
阿拉丁 |
1A-116
|
A649457-25mg
|
≥99% |
1430208-73-3 |
25mg
|
¥ 4600.9
|
期货,请咨询 |
阿拉丁 |
1A-116
|
A649457-10mg
|
≥99% |
1430208-73-3 |
10mg
|
¥ 2300.9
|
期货,请咨询 |
阿拉丁 |
1A-116
|
A649457-100mg
|
≥99% |
1430208-73-3 |
100mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
Azithromycin-d3
|
A649448-1mg
|
≥95% |
163921-65-1 |
1mg
|
¥ 4300.9
|
期货,请咨询 |
阿拉丁 |
Acevaltrate
|
A649443-5mg
|
≥99% |
25161-41-5 |
5mg
|
¥ 1100.9
|
期货,请咨询 |
阿拉丁 |
Acevaltrate
|
A649443-50mg
|
≥99% |
25161-41-5 |
50mg
|
¥ 5400.9
|
期货,请咨询 |
阿拉丁 |
Acevaltrate
|
A649443-25mg
|
≥99% |
25161-41-5 |
25mg
|
¥ 3400.9
|
期货,请咨询 |
阿拉丁 |
Acevaltrate
|
A649443-10mg
|
≥99% |
25161-41-5 |
10mg
|
¥ 1700.9
|
期货,请咨询 |
阿拉丁 |
Acevaltrate
|
A649443-100mg
|
≥99% |
25161-41-5 |
100mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
ARM1
|
A649420-5mg
|
≥99% |
68729-05-5 |
5mg
|
¥ 900.9
|
期货,请咨询 |
阿拉丁 |
ARM1
|
A649420-25mg
|
≥99% |
68729-05-5 |
25mg
|
¥ 3000.9
|
期货,请咨询 |
阿拉丁 |
ARM1
|
A649420-1mg
|
≥99% |
68729-05-5 |
1mg
|
¥ 342.9
|
期货,请咨询 |
阿拉丁 |
ARM1
|
A649420-10mg
|
≥99% |
68729-05-5 |
10mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
AAPK-25
|
A649418-5mg
|
≥98% |
2247919-28-2 |
5mg
|
¥ 2900.9
|
期货,请咨询 |
阿拉丁 |
AAPK-25
|
A649418-50mg
|
≥98% |
2247919-28-2 |
50mg
|
¥ 11800.9
|
期货,请咨询 |
阿拉丁 |